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Abstract Lipid antigens are presented to T cells by the CD1
family of proteins. In this study, we characterize the complete
dog (Canis familiaris) CD1 locus, which is located on
chromosome 38. The canine locus contains eight CD1A
genes (canCD1A), of which five are pseudogenes, one
canCD1B, one canCD1C, one canCD1D, and one canCD1E
gene. In vivo expression of canine CD1 proteins was shown
for canCD1a6, canCD1a8, and canCD1b, using a panel of
anti-CD1 monoclonal antibodies (mAbs). CanCD1a6 and
canCD1a8 are recognized by two distinct mAbs. Further-
more, we show differential transcription of the three
canCD1A genes in canine tissues. In canine skin, the
transcription level of canCD1A8 was higher than that of
canCD1A6, and no transcription of canCD1A2 was detected.
Based on protein modeling and protein sequence alignment,
we predict that both canine CD1a proteins can bind different
glycolipids in their groove. Besides differences in ectodomain
structure, we observed the unique presence of three types of
cytoplasmic tails encoded by canCD1A genes. cDNA
sequencing and expressed sequence tag sequences confirmed
the existence of a short, human CD1a-like cytoplasmic tail of
four amino acids, of an intermediate length form of 15 amino
acids, and of a long form of 31 amino acids.
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Introduction
Antigen presenting molecules play an important role in the
adaptive immune system. The well-known major histocom-
patibility complex (MHC) class I and class II antigen-
presentingmolecules havebeenfoundinall jawed vertebrates
studied so far. In mammals and birds, an additional antigen
presenting lineage has been identified: the nonpolymorphic
CD1 family of glycoproteins consisting of CD1a, CD1b,
CD1c, CD1d, and CD1e. The remarkable difference between
CD1 and MHC is that CD1 molecules present foreign and
self-lipid antigens, rather than peptides to Tcells (Beckman et
al. 1994; Beckman et al. 1996; Spada et al. 1998;D eL i b e r o
and Mori 2005; Barral and Brenner 2007). It has been shown
that different classes of lipid antigens are presented by
different CD1 isoforms. The small binding groove of CD1a
allows the binding of mycobacterial lipopeptides and
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Onderstepoort 0110, South Africasulfatide sphingolipid (Shamshiev et al. 2002; Moody et al.
2004; Zajonc et al. 2005), whereas CD1b has the largest
binding groove of all CD1 isoforms and is capable to bind
lipid antigens with much longer alkyl chains, such as
mycolyl lipids (Beckman et al. 1994; Moody et al. 1997;
Ernst et al. 1998; Niazi et al. 2001). Not only the size and
shape of the CD1 groove structure but also intracellular
trafficking determines which lipid antigens are presented by
which CD1 isoform. Human CD1a has been shown to traffic
to early endosomes were it samples lipid antigens and
translocates back to the cell surface. Human CD1b, CD1c,
and CD1d traffic to lysosomes and/or late endosomal
compartments within the cell where they encounter other
types of lipid antigens (Sugita et al. 1996; Jackman et al.
1998;S u g i t ae ta l .1999; Briken et al. 2000; Brigl and
Brenner 2004;S u g i t ae ta l .2007).
Another difference between CD1 isoforms is their expres-
sion pattern and the type of Tcell they activate. Group 1 CD1
molecules (CD1a, CD1b, and CD1c) are expressed on
professional antigen-presentingcells. Human Langerhans cells
in the skin are known for their high expression of CD1a, while
dermal dendritic cells express CD1b and CD1c (Dougan et al.
2007). It has been shown that group 1 CD1 molecules present
mycobacterial antigens to T cells (Beckman et al. 1994;
Moody et al. 2000; Pena-Cruz et al. 2003; Moody et al.
2004). Group 2 CD1 molecules (CD1d) are expressed on
several types of antigen-presenting cells but are also present
on a wide range of nonhematopoietic cells. CD1d is the
restricting element that selects and activates invariant natural
killer Tcells (Bendelac et al. 1995;C h e ne ta l .1997; Kawano
et al. 1997; Gumperz et al. 2002).
The human CD1 locus contains one gene for each of the
different CD1 isoforms (Calabi and Milstein 1986; Shiina
et al. 2001). However, as a result of CD1 gene duplication
and deletion during mammalian evolution, the number of
CD1 molecules and their genes is different in other species.
For example, the guinea pig CD1 locus consists of four
CD1B genes and three CD1C genes. It is thought that the
loss of CD1 isoform diversity and their specific function is
at least partly recovered by gene duplication and neo-
functionalization of CD1 molecules (Dascher et al. 1999).
In this study, the complete dog CD1 locus is characterized.
We show the differential expression of CD1A genes in canine
skin and the unique in vivo expression of two distinct CD1a
proteins.
Materials and methods
In silico identification of canine CD1 genes
Blast searches in the canine genome (Broad Institute of
MIT/Harvard, CanFam 2.0 version 46.2d; coverage 7.5),
available at www.ensembl.org/Canis_familiaris, were per-
formed with α1a n dα2 domain nucleotide sequences of all
human CD1 isoforms. To compare canine CD1A genes
with other mammalian CD1A genes, we used the known
CD1A genes in GenBank of human (NM001763), rabbit
(AF276977 and AF276978), pig (AF059492), and cattle
(DQ192541). To identify cat CD1A genes, we performed a
blast search with the human α1 and α2 domain nucleotide
sequences of human CD1A in the feline genome (Agencourt
Bioscience, CAT version 46.1b; coverage 2). Blast searches
for expressed sequence tag (EST) sequences were performed
at the National Center for Biotechnology Information
website (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).
Canine tissue collection and cDNA synthesis
Tissue samples were obtained from healthy adult dogs
(Beagles).Peripheralbloodmononuclear cells (PBMCs) were
isolated from dog blood by standard Ficoll–Hypaque gradient
centrifugation. Skin samples were processed using a Bio-
pulverizer and homogenized using a mini-Turrax (IKA).
Intestine tissue (duodenum, jejunum, and colon) was washed
and incubated in phosphate-buffered saline (PBS) with
0.75 mg/ml ethylenediamine tetraacetic acid, 5% fetal calf
serum (FCS), and 50 μg/ml gentamicin at 37°C for 1 h to
obtain intestinal cells. Single-cell suspensions were freshly
prepared from the liver, spleen, lymph node, and thymus.
Caninetissuewas collectedaccordingtothe regulations ofthe
Animal Ethical Committee of the University of Utrecht, The
Netherlands (protocol number 2007.II.06.152). From all
collected tissues, ribonucleic acid (RNA) was isolated using
the RNeasy kit (Qiagen) followed by complementary deoxy-
ribonucleic acid (cDNA) synthesis with Multiscribe reverse
transcriptase (Applied Biosystems).
PCR, cloning, and sequence analysis
Polymerase chain reactions (PCRs) were performed with
Pfu Turbo polymerase (Stratagene) according to the
protocol of the manufacturer under the following cycling
conditions: an initial denaturation of 7 min at 95°C,
followed by 40 cycles of 15 s at 95°C, 45 s at a primer-
specific annealing temperature, 30 s at 72°C, followed by a
final elongation step of 5 min at 72°C. PCR for full-length
CD1 genes was performed using thymus cDNA as a
template and the following primers: canCD1A6 forward
5′-GCAAGAGAAAGACATCTGCAAACACG and re-
verse 5′-CCCTGGACTGACCTCAAGGCA at annealing
temperature (Ta) of 61°C; canCD1A8 forward 5′-GCAA
GAGAAAGACATCTGCAAACACG and reverse 5′-
CACRGGGAGTGGCCAGGAC at Ta of 61°C; canCD1B
forward 5′-CAGCCCACTGTCCGGGGAG and reverse 5′-
AAGAAGAGTTCATGAGATGGCGAGGG at Ta of 61°C;
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and reverse 5′-GGGAGGCATGGTGACGAAGC at Ta of
59°C. The CD1D gene was not amplified in full length due
to an unknown sequence upstream from the α2 domain
sequence; therefore, canCD1D forward was designed in the
α2d o m a i n5 ′-GATCCTGAGTTTCCAAGGGTCTCAC
and reverse 5′-GCTGAGGGTGAAGAAAGGCTGC in
the 3′ untranslated region at Ta of 65°C. To determine
the messenger RNA expression of the different CD1A
genes in dog tissue, gene-specific forward primers and a
general reverse primer were designed: canCD1A2 forward
in α2d o m a i n5 ′-AGCTGCGCATTGGAGAACCTTTC;
canCD1A6 forward in α1d o m a i n5 ′-GGACAGTGA
CTCTGGCACTTTCTTG; canCD1A8 forward in α1
domain 5′-CATACACCATCCGATCCCCTTCC; canCD1A
general reverse primer in α3d o m a i n5 ′-AGACTGCT
GTGTCTCACACGGC at a Ta of 59°C. Gel electropho-
resis (10% agarose gel) was performed for 1 h at 100 V.
After PCR, full-length CD1 PCR products were isolated
from the gel. Products were ligated in a pCR4Blunt-
TOPO vector (Invitrogen) to transform One Shot TOP10
cells (Invitrogen). Vector DNA of single colonies was
sequenced by BaseClear (Leiden, The Netherlands). The
obtained sequences were compared to the canine CD1
sequences obtained from the ensemble database (www.
ensembl.org/Canis_familiaris). The ExPASy Translate Tool
was used (www.expasy.ch/tools/dna) for translation into
amino acids. All alignments were performed with ClustalW
(align.genome.jp).
Monoclonal antibodies and staining procedures
The expression of CD1 by canine thymocytes, 030-D
histiocytosis cell line (Levy et al. 1995), and 293T cells
transfected with canCD1 was measured using a FACScali-
bur flow cytometer (Becton Dickinson). Transfection of
293T was performed with full-length CD1 gene sequences
in pcDNA3.1+ vector (Invitrogen) using FuGENE6
(Roche) as transfection reagent. Anti-canine CD1 mono-
clonal antibodies (mAbs) CA13.9H11 (IgG1), CA9.AG5
(IgG1), anti-feline CD1a Fe1.5F4 (IgG1), and anti-feline
CD1c Fe5.5C1 (IgG1) were provided by Dr. P.M. Moore
(School of Veterinary Medicine, University of California,
Davis, CA, USA). Anti-human CD1a (OKT6; IgG1), CD1b
(BCD1b3; IgG1), and CD1c (F10/21A3; IgG1) were
provided by Dr. D.B. Moody (Brigham and Women’s
Hospital and Harvard Medical School, Boston, MA, USA).
Anti-human CD1a (WM-35; IgG2b) was obtained from
ImmunoTools. Anti-bovine CD1 CC20 (IgG2a) was pro-
vided by Dr. C.J. Howard (Institute for Animal Health,
Compton, UK); CC14 (IgG1) was provided by Dr. J.C.
Hope (Institute for Animal Health Compton, UK); 20.27
SBU-T6 (IgG1) was obtained from the European Collection
of Cell Cultures. Goat anti-mouse fluorescein isothiocya-
nate (GAM-FITC) was used as secondary antibody.
Primary antibodies were diluted in PBS with 0.1% sodium
azide and 2% FCS. Canine thymocytes, 030-D cell lines,
and CD1-transfected 293T cells were incubated with
primary antibody for 30 min at 4°C, followed by incubation
with GAM-FITC (BD Biosciences) for 30 min at 4°C.
Protein modeling
Canine CD1a protein models were generated using the
Swiss Model Server with human CD1a (PDB code 1ONQ)
as a template. The model was visualized using PyMol
(pymol.sourceforge.net). The program APBS (Baker et al.
2001) was used to calculate the electrostatic surface
potentials with electronegative in red and electropositive
in blue (−30 to +30 kT/e).
Results
Characterization of the canine CD1 locus
The canine CD1 (canCD1) genes are located close to the
telomeric end of chromosome 38 between 26.30 and
26.55 Mbp. The boundaries of the canCD1 locus are
formed by the CD1-unrelated Kirrel and olfactory receptor
gene group of which OR10T2 was the first gene adjacent to
the CD1 locus. The canCD1 locus contains six gaps of 61–
578 nucleotides, which are located between the CD1 genes,
and one gap of 2,852 nucleotides that lies between base pairs
26,503,057 and 26,505,908 of which 75% of the nucleotide
sequence was present in a draft sequence deposited by the
Broad Institute (AC183576). The canCD1 locus consists of
thefollowinggenesfrom thetelomericendtothecentromere:
one canCD1D gene, eight canCD1A genes, one canCD1C,
one canCD1B, and one canCD1E gene (Fig. 1). The canine
CD1 genes have the same orientation as human CD1 genes
except for CD1B, which in the human CD1 locus has an
opposite orientation compared to the other human CD1
isoforms.
Of the eight CD1A genes, three CD1A genes (can-
CD1A2, canCD1A6, canCD1A8) revealed a complete
sequence without obvious characteristics of pseudogenes
like internal stop codons, frameshift mutations, and splice
site mutations. Five CD1A genes were considered to be
pseudogenes (canCD1A1, canCD1A3, canCD1A4, can-
CD1A5, canCD1A7). During the in silico study, we found
a fourth full-length CD1A gene; however, due to its high
nucleotide identity with canCD1A8 (93%) and because it
was not assigned to chromosome 38 by Ensemble (CanFam
2.0, www.ensembl.org), we assume that this is an allelic
variation and named these two CD1A8 genes canCD1A8.1
Immunogenetics (2008) 60:315–324 317and canCD1A8.2, accordingly. Furthermore, full-length
genes for canCD1B, canCD1C, and canCD1E were present
in the dog CD1 locus. In the draft sequence (AC183576),
we found a part of the canine CD1D gene. In this sequence,
it was not possible to identify the leader fragment, the first
intron, and a small part of the α1 domain of canCD1D
because the nucleotide sequence was unknown, but most of
the α1 domain and the complete 3′ part of the canCD1D
gene were intact. Because the map of the locus is complete
in the sense that the locus between the adjacent non-CD1
Kirrel and olfactory receptor genes did not contain any gaps
big enough to contain a CD1 gene, we assume that we
identified all canCD1 genes.
Cloning of full-length canCD1 cDNAs
Full-length cDNAs were cloned using a PCR-based strategy.
The forward primer was designed to anneal upstream of the
start codon, based on the available genomic sequences, and
the reverse primer was designed to bind downstream of the
predicted stop codon. Full-length canCD1A6 (GenBank
EU373508/protein_id ACB12088) and canCD1A8.2 (Gen-
Bank EU373509/protein_id ACB12089) transcripts were
cloned. We have not been able to obtain full-length CD1A2,
which may be due to a low transcription level in thymus
cDNA and high homology with canCD1A8 at the sites
where the primers were designed to bind. The ectodomain of
the canCD1A6 transcript was 97% identical at the amino
acid level to the predicted canCD1A6 transcript from the in
silico study.The canCD1A8transcript showed greater amino
acid identity to the predicted canCD1A8.2 transcript than to
the predicted canCD1A8.1 transcript (98% and 88%,
respectively). A single full-length canCD1B transcript was
cloned (GenBank EU373510/protein_id ACB12090) and
showed 99% amino acid identity with the predicted
canCD1B. Two different full-length canCD1C transcripts
were obtained from thymus-derived cDNA of a single dog
(Beagle), which was named dog A. The two different
transcripts canCD1C clone 1 and clone 2 (GenBank
EU373511/protein_id ACB12091 and EU373512/protein_id
ACB12092) both showed 98% amino acid identity to the
predicted canCD1C transcript. These small nucleotide alter-
ationscomparedtothepredictedsequencemightbecausedby
PCR artifacts and/or allelic variation. A third unique full-
length canCD1C, clone 3 (GenBank EU373513/protein_id
ACB12093), was obtained from cDNA derived from the 030-
D canine histiocytosis cell line and showed 99% identity with
the predicted canCD1C. From thymus-derived cDNA, a
partial canCD1D transcript was cloned containing a fragment
of the α2 domain, full-length α3 domain, a transmembrane
region, and a cytoplasmic tail.
Recognition of canCD1 molecules by monoclonal
antibodies
To determine which antibodies recognize the canine CD1
isoforms, we tested a panel of mAbs specific for CD1 in
humans, cattle, sheep, and cat. We also tested the two anti-
canine CD1 mAbs CA13.9H11 and CA9.AG5 for their
specificity for canCD1. Results are summarized in Table 1.
Freshly isolated thymocytes of dog A were recognized by
the anti-canine mAb CA13.9H11 and CA9.AG5, the anti
human mAb BCD1b3, the anti-bovine mAb CC20 and
SBUT6, and the anti-feline mAb Fe1.5F4 and Fe5.5C1 but
not by the anti-human CD1a mAb OKT-6 and anti-human
CD1c mAb F10/21A3. Using 293T cells transfected with
full-length canCD1 transcripts, we found that canCD1a6 is
recognized by the anti-feline CD1a Fe1.5F4 but not by anti-
canine CD1 CA13.9H11. The opposite was true for the
recognition of canCD1a8.2 (Fig. 2). This implies that two
different mAbs recognize two different in vivo expressed
canCD1a proteins. The anti-canine CD1 antibody CA9.AG5
did not recognize canCD1a6, canCD1a8.2, and canCD1b
protein on transfected 293T cells; however, it did recognize
an unidentified epitope on canine thymocytes.
293T cells transfected with the full-length canCD1C
transcript clone 1 and 2, derived from dog A, or canCD1C
transcript clone 3, derived from the 030-D cell line, were
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Fig. 1 Complete gene map of the canine CD1 locus located on
chromosome 38. Full-length canine CD1 genes without characteristics
of pseudogenes are given in bold. Pseudogenes are marked with Ψ.
Exact location of CD1 genes: CD1D: unknown–26502267; CD1A1:
26479022–26477829; CD1A2: 26470445–26467658; CD1A3:
26452485–26449619; CD1A4: 26439630–26436644; CD1A5:
26418868–26416544; CD1A6: 26398237–26395316; CD1A7:
26378486–26375657; CD1A8: 26363063–26360148; CD1B:
26332684–26329120; CD1C: 26344187–26341100; CD1E:
26310804–26308062. Asterisk, The location of the allelic variant of
CD1A8 is: 81854142–81857071 on an unknown chromosome
(Ensemble)
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Unfortunately, we have not been able to confirm expression
of the three full-length canCD1c cDNAs by staining with
any mAb or by alternative methods. The mAbs CA13.9H11
and CA9.AG5 have both been suggested to recognize
canCD1 (Moore et al. 1996). In this study, we show that
CA13.9H11 recognizes canCD1a8.2. We have not been
able to show CD1 recognition by CA9.AG5. The mAb
CA9.AG5 recognizes a molecule expressed on thymocytes
of approximately 60% of all dogs, suggesting that this mAb
is specific for an allotype or allelic variation of an
unidentified gene product. In our study, the same animal
(dog A) was used for flowcytometric analysis of ex vivo
thymocytes and for cDNA synthesis from thymocytes. The
ex vivo thymocytes of this animal were recognized by
CA9.AG5, but the two slightly different CD1c cDNAs were
not. This makes it unlikely that the lack of recognition by
the anti-canine CD1 antibodies CA13.9H11 and CA9.AG5
is caused by allelic differences in canCD1c.
Transcription of CD1A genes in different tissues
Transcription levels of the three different CD1A genes were
determined in different tissues of a healthy Beagle. The
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Fig. 2 Flow cytometric analysis
of expression canCD1 on tran-
fectant 293T cells. Cells are
transfected with canCD1A6
(a–b) or with canCD1A8.2 gene
transcripts (c–d). Staining was
performed with anti-canine CD1
mAb CA13.9H11 and with anti-
feline CD1a mAb, followed by
GAM-FITC
Table 1 A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine
histiocytosis cell line
mAb Canine thymocytes 030-D canCD1a6 canCD1a8.2 canCD1b Published reactivity Reference
CA13.9H11 + + − + − canCD1 Moore et al. 1996
CA9.AG5 + −− − − canCD1 Moore et al. 1996
WM-35 − + −− − huCD1a
BCD1b3 + + − + + huCD1b
SBUT6 + +/−− + + boCD1a/boCD1b3 Mackay et al. 1985
CC20 + + − + − huCD1b/boCD1b3 Howard et al. 1993
Fe1.5F4 + − + −− felCD1a Woo and Moore 1997
Fe5.5C1 + + −− − felCD1c Woo and Moore 1997
Immunogenetics (2008) 60:315–324 319expression of different CD1A genes in canine lymphoid
and nonlymphoid tissues is shown in Fig. 3. The transcrip-
tion of canCD1A2 was only found in the thymus, whereas
canCD1A6 and canCD1A8 were transcribed in the thymus,
lymph node, spleen, liver, skin, and PBMCs. It is
interesting to note that, in skin, canCD1A8 is clearly
expressed at a much higher level than the other CD1A
genes. Results are representative of three independent
experiments.
Comparison of canCD1a6 and canCD1a8 models
and canine CD1 cytoplasmic tails
The protein sequence of the two different canCD1a
molecules of which a full-length transcript was derived is
very similar. However, single amino acid differences at key
positions in the binding groove can result in noticeable
differences in the structure of the binding groove and,
moreover, in the ability to bind and present lipids. To
predict whether the overall architecture of the antigen-
binding grooves of canCD1a is similar to that of human
CD1a, we generated models of the two in vivo expressed
canCD1a molecules using the Swiss Model server
(Schwede et al. 2003) and compared these to their human
counterpart (Fig. 4a). Both the structural models and the
sequence comparison (Fig. 4b) suggest that both canCD1a6
and canCD1a8, like human CD1a (Zajonc et al. 2005), have
a hydrophobic binding groove with a buried A′ pocket and
a more exposed F′ pocket. Key structural features such as
the A′ pole are conserved (Phe70 and Val/Ile12), as well as
an A′ roof is predicted (residues 66, 69, 161, 165). In
addition, the A′ pocket of canCD1a8 is predicted to be open
ended (Gly28 vs. Val or Ala), similar to mouse CD1d.
Therefore, the length of bound lipids in that pocket could
be longer than C18, as observed for human CD1a (Zajonc et
al. 2003). Clearly the shape of the individual pockets will
be slightly different, as not all groove-lining residues are
conserved. However, the overall size of the CD1a grooves
appears to be similar. Furthermore, the groove opening of
canCD1a8 appears slightly larger than the opening of
canCD1a6. Furthermore, the residues lining the opening
to the CD1a groove (F′ portal) are the least conserved
between the CD1a molecules. As these residues were
shown to bind the glycolipid headgroup, we speculate that
the three CD1a proteins have the capacity to bind different
glycolipid antigens.
Furthermore, different antigens are presented by CD1
proteins due to sampling in different endocytic compart-
ments. This intracellular trafficking of CD1 is directed by
the presence or absence of a sorting motif in the
cytoplasmic tail. We aligned cytoplasmic tail sequences of
the three canine CD1a proteins with the closely related
carnivore species cat and to other, more distantly related
mammalian species (Fig. 5a). To make this alignment, we
performed a blast search in the cat genome and found four
CD1A genes of which two contained the nucleotide
sequence of the cytoplasmic tail, and we used known
CD1a cytoplasmic tail sequences of human (NM001763),
rabbit (AF276977 and AF276978), pig (AF059492), and
cattle (DQ192541). Except for human CD1a and can-
CD1a8.2, all other known mammalian CD1a cytoplasmic
tails are long. CanCD1a2 and canCD1a8.1 have an even
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Fig. 3 Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, β-actin was included
320 Immunogenetics (2008) 60:315–324longer cytoplasmic tail of 31 amino acids, which was
confirmed by the identification of transcripts of can-
CD1A8.1 (DN877612) and canCD1A2 (DN409579) that
included these cytoplasmic tails in the EST databases. No
known sorting motif was observed in any of the canine
CD1a cytoplasmic tail sequences.
The cytoplasmic tails of the other canine CD1 isoforms
were aligned with the amino acid sequences of cytoplasmic
tails of their human homologs (Fig. 5b). Like in their
human counterparts, the tyrosine trafficking motif YXXZ
was present in all three canine sequences. However, the
human CD1c tail contains a dileucine motif, which is not
present in canCD1c.
Discussion
The canine CD1 locus located on chromosome 38
contained all known CD1 isoforms. We identified a
remarkable large number of CD1A homologs, three of
which were shown to be full-length canCD1A genes and
five were considered pseudogenes. Intensive duplication of
1
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b Leader 1 domain α
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3 domain
Tm
. pl. tail
canCD1a6 MLFLQLVLLVVLLPEGDSEDAFQEPVSFQVILTTSFYNSSWTQNLASAWLDELQTHSWDS 42
canCD1a8 MLFLQLVLLAVLLLGGDSEDDSQEPISFRIILTTSFYNSSSTQNQGSAWLDELQTHGWNN 42
humanCD1a MLFLLLPLLAVLPGDGN-ADGLKEPLSFHVTWIASFYNHSWKQNLVSGWLSDLQTHTWDS 42
canCD1a6 43 DSGTFLFLWPWAKGKLSKEELIERERTFHTFSIRFPLIFQDSVSDWQLEYPFQVQMAEGC 102
canCD1a8 43 KTGAFRYLQPWSKGNFSNEELLEVQNLFYTYTIRSPSTFHNHIRDWQLEYPFQIQLVLGC 102
humanCD1a NSSTIVFLCPWSRGNFSNEEWKELETLFRIRTIRSFEGIRRYAHELQFEYPFEIQVTGGC 102
canCD1a6 103 GLYFGKPSVGFMQIAYQGSDLVSFQNKSWWPSPKGGRRAQQVCKLLNQYHVVNLRIHSHI 162
canCD1a8 103 DSHFGEASAGFLQLAYQGSDVLSFQNTSWRPSPEGGSRAQKVCSLFNQDHVSHEIVRKLL 162
humanCD1a 103 ELHSGKVSGSFLQLAYQGSDFVSFQNNSWLPYPVAGNMAKHFCKVLNQNQHENDITHNLL 162
canCD1a6 163 NDFCPHYLLGLLDAGKGDLHRQVRPEAWLSAGPSPSSDHLQLVCHVSGFYPKPVWVTWMR 222
canCD1a8 163 NEICPRILLSLLDAGKVDLQRQVRPEAWLSTGPSPGSGHLRLVCHVSGFYPKPVWVMWMR 222
humanCD1a 163 SDTCPRFILGLLDAGKAHLQRQVKPEAWLSHGPSPGPGHLQLVCHVSGFYPKPVWVMWMR 222
canCD1a6 223 GEQEQQGSWRGDVLPHADGTWYLQVSLDVKAKEVAGLSCRVRHSSLGGQDMVLHWERPHS 282
canCD1a8 223 GEQEQTGSQRGDVLPHADGTWYLQVSLDVKAKEAAGLSCRVRHSSLGGQDMVLHWEQLPS 282
humanCD1a 223 GEQEQQGTQRGDILPSADGTWYLRATLEVAAGEAADLSCRVKHSSLEGQDIVLYWEHHSS 282
canCD1a6 283 MGLVFLVVIVPLVLLAGLAWCLWKRWKTHNRPQCTDFPLK 322
canCD1a8 283 MGLVFLVVIVPLVLLAGLVWWLWKRWKAH----------- 311
humanCD1a 283 VGFIILAVIVPLLLLIGLALWFRKRCFC------------ 310
human CD1a dog CD1a8 dog CD1a6
1
2
43
Cyt
α
α
Fig. 4 a Molecular surface of human CD1a, canine CD1a6, and
canine CD1a8. The α1 and α2 domains are depicted, and the opening
to the binding groove is in the center of each molecule. Note that the
bottom of the canCD1a6 binding groove appears electronegative due
to the presence of Glu100; however, overall, the binding grove is
hydrophobic. Furthermore, residue 100 is not highlighted in Fig. 5b,
as it was not a residue contacting the sulfatide ligand in the human
CD1a-sulfatide structure (1onq). Electrostatic potentials were calcu-
lated using APBS and PyMol; red is electronegative, and blue is
electropositive (−30 to +30 kT/e). b Multiple-sequence alignment
(CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human
CD1a, colored by sequence identity (black) and structural features (in
color). Residues contributing to the CD1a binding groove of human
CD1a are highlighted in yellow. These residues were originally
identified base on their interaction with the sulfatide ligand (PDB
code 1onq). Darkgreen,A ′ pole; green, terminal residue restricting the
length of the A′ pocket; cyan,A ′ roof; blue, residues at the opening to
the CD1a groove (F′ portal). Residues colored in red or gray are
similar. Residues that are highlighted but not colored in red are
predicted not to dramatically alter the structural feature. Canine
residues not highlighted according to their human counterparts are
predicted to have an altered structural element
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three distinct CD1a proteins is characteristic for the canine
CD1 locus. This is the first study showing differential
transcription of two CD1A genes for which in vivo protein
expression is confirmed. These differences in expression
might indicate differences in function between the CD1a
molecules in canine skin. So far, it is unknown whether these
different CD1a molecules are present on the same antigen-
presenting cell in the canine skin or that different antigen-
presenting cells express different canCD1a molecules.
Stationary epidermal Langerhans cells as well as migrating
dermal Langerhans cells have a high CD1a expression.
Besides Langerhans cells, also a subpopulation of dermal
dendritic cells has been reported to express CD1a (Angel et
al. 2006). These professional antigen-presenting cells play
an important role in the initiation of the immune response
and are able to activate T cells in a CD1a-restricted manner
(Pena-Cruz et al. 2003; Kissenpfennig et al. 2005).
Increased numbers of CD1c
+ Langerhans cells have been
described in lesional skin of dogs with atopic dermatitis
(Olivry et al. 1996, 1997, 2006). In these two studies, the
primary monoclonal antibody CA13.9H11 was used to detect
canCD1c. However, from our study using 293T cells trans-
fected with the different CD1 isoforms, we know that
CA13.9H11 recognizes canCD1a8.2. It is possible that
CA13.9H11 recognizes both CD1a8.2 and canCD1c, but we
have not been able to demonstrate recognition of canCD1c by
this mAb so far. Therefore, it is possible that the reported
expressionofCD1onLangerhanscells inlesionalcanineskin
is reflecting expression of canCD1a8 rather than canCD1c.
The current assignment of canCD1c being the molecule
recognized by anti-canine CA13.9H11 has not been invali-
dated inthisstudy. However, 293Tcells transfectedwiththree
differentfull-lengthcanCD1Ctranscripts werenotrecognized
by CA13.9H11. The mAb CA9.AG5 has been used to
determine canCD1a expression on Langerhans cells (Olivry
et al. 1996). In our study, 293T cells transfected with
canCD1A6, canCD1A8.2, canCD1B, or the three canCD1C
sequences were not recognized by CA9.AG5. It is possible
that the mAb CA9.AG5 does not recognize canCD1 but an
unknown epitope on canine thymocytes.
The current study shows the expression of two different
types of canine CD1a proteins. We found differences in the
ectodomain between the two molecules and the unique
presence of two different cytoplasmic tails, which might
contribute to a greater scope of glycolipid antigen presen-
tation and improved skin immunity.
Rabbits are the only other mammalian species that are
known to have two different CD1a proteins (Hayes and
Knight 2001). However, cytoplasmic tails of the two rabbit
CD1a proteins show higher sequence identity compared to
dogs. Based on the presence of long cytoplasmic tails in all
mammalian species other than primates, it is likely that the
canCD1A gene encoding a short cytoplasmic tail (can-
CD1A8.2) is derived from a paralog with a long cytoplas-
mic tail. Single-nucleotide point mutations may have
introduced a stop codon within the long tail sequence
resulting in a shorter tail. Indeed, the 31-amino acid-long
cytoplasmic tails of canCD1a2 and canCD1a8.1 can be
changed into the short, four-amino acid-long cytoplasmic
tail like the one in CD1a8.2, by a single point mutation.
The cytoplasmic tail of the human CD1a ortholog does not
contain any known endosomal targeting sequences (Sugita
et al. 2007). However, whether this also holds for CD1a
molecules of other mammalian species and whether they
traffic like their human counterpart are unknown. Like their
human homologs, a tyrosine motif was present in the
cytoplasmic tail of canCD1b and canCD1d. This might
indicate that these canine CD1 molecules traffic to similar
compartments as human CD1b and human CD1d compart-
ments to sample lipid antigens. Canine CD1c also
contained a tyrosine-trafficking motif within its cytoplasmic
tail, but unlike human CD1c, a dileucine motif was not
present.
CD1 gene duplication might be driven by the lack of
certain CD1 isoforms. One of the four CD1B genes found
in guinea pig seems to replace the loss of a guinea pig
CD1A gene (Hiromatsu et al. 2002). The extensive canine
CD1A isoform duplication found in this study seems not to
be driven by the limited repertoire of other CD1 isoforms
because all isoforms are present within the canine CD1
locus. This suggests that for canCD1A, gene duplication
humanCD1a CFC
canCD1a2 WKAHWRPQCMDFPSEQEPSSPSSSTYLNPAQH
canCD1a8.2 WKAH
canCD1a6 WKTHNRPQCTDFPLK
felCD1a1 (p) WKSHETPQCTGLPLE
felCD1a2 (p) WKSHWRHQCTGLPLE
rabbitCD1a1 WIHHG.PLETLLPLQ
rabbitCD1a2 WSHHGSPN.SLLPLK
pigCD1.1 WK.HCDPSSALHRLE
boCD1a WTHRESPSS.VLPLE
canCD1b RSYQSIS
humanCD1b RSYQNIP
canCD1c CSYQDIP
humanCD1c CSYQDIL
canCD1d RSYQDIL
humanCD1d TSYQGVL
a b
canCD1a8.1 WKAHWRPQCTDFPSEQEPSSPGSSTYLNPAQH
Fig. 5 a Alignment of the CD1a cytoplasmic tail sequences of
different mammalian species. Tail sequences that were not confirmed
by cDNA sequencing but only predicted from the genome are marked
accordingly (p). b Alignment of cytoplasmic tail sequences of
canCD1b, canCD1c, and canCD1d with their human orthologs. The
tyrosine trafficking motif (YXXZ) is underlined
322 Immunogenetics (2008) 60:315–324was driven by another reason than the replacement of loss
of other CD1 isoforms.
The presence of multiple CD1A genes in dogs, their
differential transcription in healthy skin, and upregulation at
least for canCD1a8 during allergic skin diseases (Olivry et
al. 1996; 1997) in combination with their potential to
present different glycolipid antigens suggest different
functions in skin immunity.
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